img

Global Blood Albumin Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 95 | Industry : Pharma & Healthcare

Publisher : Q | Format : PDF

Global Blood Albumin Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Human Serum Albumin
Bovine Serum Albumin


Segment by Application


Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group

Table of Content

1 Blood Albumin Market Overview
1.1 Product Overview and Scope of Blood Albumin
1.2 Blood Albumin Segment by Type
1.2.1 Global Blood Albumin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Human Serum Albumin
1.2.3 Bovine Serum Albumin
1.3 Blood Albumin Segment by Application
1.3.1 Blood Albumin Sales Comparison by Application: (2021-2027)
1.3.2 Therapeutics
1.3.3 Vaccine Ingredient
1.3.4 Culture Medium Ingredient
1.3.5 Other
1.4 Global Blood Albumin Market Size Estimates and Forecasts
1.4.1 Global Blood Albumin Revenue 2016-2027
1.4.2 Global Blood Albumin Sales 2016-2027
1.4.3 Blood Albumin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Blood Albumin Market Competition by Manufacturers
2.1 Global Blood Albumin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Blood Albumin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Blood Albumin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Blood Albumin Manufacturing Sites, Area Served, Product Type
2.5 Blood Albumin Market Competitive Situation and Trends
2.5.1 Blood Albumin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Blood Albumin Players Market Share by Revenue
2.5.3 Global Blood Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Blood Albumin Retrospective Market Scenario by Region
3.1 Global Blood Albumin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Blood Albumin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Blood Albumin Market Facts & Figures by Country
3.3.1 North America Blood Albumin Sales by Country
3.3.2 North America Blood Albumin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Blood Albumin Market Facts & Figures by Country
3.4.1 Europe Blood Albumin Sales by Country
3.4.2 Europe Blood Albumin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Blood Albumin Market Facts & Figures by Region
3.5.1 Asia Pacific Blood Albumin Sales by Region
3.5.2 Asia Pacific Blood Albumin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Blood Albumin Market Facts & Figures by Country
3.6.1 Latin America Blood Albumin Sales by Country
3.6.2 Latin America Blood Albumin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Blood Albumin Market Facts & Figures by Country
3.7.1 Middle East and Africa Blood Albumin Sales by Country
3.7.2 Middle East and Africa Blood Albumin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Blood Albumin Historic Market Analysis by Type
4.1 Global Blood Albumin Sales Market Share by Type (2016-2021)
4.2 Global Blood Albumin Revenue Market Share by Type (2016-2021)
4.3 Global Blood Albumin Price by Type (2016-2021)

5 Global Blood Albumin Historic Market Analysis by Application
5.1 Global Blood Albumin Sales Market Share by Application (2016-2021)
5.2 Global Blood Albumin Revenue Market Share by Application (2016-2021)
5.3 Global Blood Albumin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Grifols Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Shire (Baxalta)
6.3.1 Shire (Baxalta) Corporation Information
6.3.2 Shire (Baxalta) Description and Business Overview
6.3.3 Shire (Baxalta) Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shire (Baxalta) Product Portfolio
6.3.5 Shire (Baxalta) Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Bio
6.5.1 Hualan Bio Corporation Information
6.5.2 Hualan Bio Description and Business Overview
6.5.3 Hualan Bio Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hualan Bio Product Portfolio
6.5.5 Hualan Bio Recent Developments/Updates
6.6 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CBPO Product Portfolio
6.6.5 CBPO Recent Developments/Updates
6.7 RAAS
6.6.1 RAAS Corporation Information
6.6.2 RAAS Description and Business Overview
6.6.3 RAAS Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 RAAS Product Portfolio
6.7.5 RAAS Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Corporation Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Kedrion Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Merck Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 LFB Group
6.10.1 LFB Group Corporation Information
6.10.2 LFB Group Description and Business Overview
6.10.3 LFB Group Blood Albumin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LFB Group Product Portfolio
6.10.5 LFB Group Recent Developments/Updates

7 Blood Albumin Manufacturing Cost Analysis
7.1 Blood Albumin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Blood Albumin
7.4 Blood Albumin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Blood Albumin Distributors List
8.3 Blood Albumin Customers

9 Blood Albumin Market Dynamics
9.1 Blood Albumin Industry Trends
9.2 Blood Albumin Growth Drivers
9.3 Blood Albumin Market Challenges
9.4 Blood Albumin Market Restraints

10 Global Market Forecast
10.1 Blood Albumin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Blood Albumin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Blood Albumin by Type (2022-2027)
10.2 Blood Albumin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Blood Albumin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Blood Albumin by Application (2022-2027)
10.3 Blood Albumin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Blood Albumin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Blood Albumin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Blood Albumin Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Blood Albumin Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Blood Albumin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Blood Albumin Covered in This Study
Table 5. Global Blood Albumin Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Blood Albumin Sales Share by Manufacturers (2016-2021)
Table 7. Global Blood Albumin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Blood Albumin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Blood Albumin Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Blood Albumin Manufacturing Sites and Area Served
Table 11. Manufacturers Blood Albumin Product Type
Table 12. Global Blood Albumin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Blood Albumin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Albumin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Blood Albumin Sales by Region (2016-2021) & (K Units)
Table 16. Global Blood Albumin Sales Market Share by Region (2016-2021)
Table 17. Global Blood Albumin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Blood Albumin Sales by Country (2016-2021) & (K Units)
Table 19. North America Blood Albumin Sales Market Share by Country (2016-2021)
Table 20. North America Blood Albumin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Blood Albumin Revenue Market Share by Country (2016-2021)
Table 22. Europe Blood Albumin Sales by Country (2016-2021) & (K Units)
Table 23. Europe Blood Albumin Sales Market Share by Country (2016-2021)
Table 24. Europe Blood Albumin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Blood Albumin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Blood Albumin Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Blood Albumin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Blood Albumin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Blood Albumin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Blood Albumin Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Blood Albumin Sales Market Share by Country (2016-2021)
Table 32. Latin America Blood Albumin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Blood Albumin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Blood Albumin Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Blood Albumin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Blood Albumin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Blood Albumin Revenue Market Share by Country (2016-2021)
Table 38. Global Blood Albumin Sales (K Units) by Type (2016-2021)
Table 39. Global Blood Albumin Sales Market Share by Type (2016-2021)
Table 40. Global Blood Albumin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Blood Albumin Revenue Share by Type (2016-2021)
Table 42. Global Blood Albumin Price (US$/Unit) by Type (2016-2021)
Table 43. Global Blood Albumin Sales (K Units) by Application (2016-2021)
Table 44. Global Blood Albumin Sales Market Share by Application (2016-2021)
Table 45. Global Blood Albumin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Blood Albumin Revenue Share by Application (2016-2021)
Table 47. Global Blood Albumin Price (US$/Unit) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. CSL Blood Albumin Product
Table 52. CSL Recent Developments/Updates
Table 53. Grifols Corporation Information
Table 54. Grifols Description and Business Overview
Table 55. Grifols Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Grifols Blood Albumin Product
Table 57. Grifols Recent Developments/Updates
Table 58. Shire (Baxalta) Corporation Information
Table 59. Shire (Baxalta) Description and Business Overview
Table 60. Shire (Baxalta) Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Shire (Baxalta) Blood Albumin Product
Table 62. Shire (Baxalta) Recent Developments/Updates
Table 63. Octapharma Corporation Information
Table 64. Octapharma Description and Business Overview
Table 65. Octapharma Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Octapharma Blood Albumin Product
Table 67. Octapharma Recent Developments/Updates
Table 68. Hualan Bio Corporation Information
Table 69. Hualan Bio Description and Business Overview
Table 70. Hualan Bio Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Hualan Bio Blood Albumin Product
Table 72. Hualan Bio Recent Developments/Updates
Table 73. CBPO Corporation Information
Table 74. CBPO Description and Business Overview
Table 75. CBPO Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. CBPO Blood Albumin Product
Table 77. CBPO Recent Developments/Updates
Table 78. RAAS Corporation Information
Table 79. RAAS Description and Business Overview
Table 80. RAAS Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. RAAS Blood Albumin Product
Table 82. RAAS Recent Developments/Updates
Table 83. Kedrion Corporation Information
Table 84. Kedrion Description and Business Overview
Table 85. Kedrion Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Kedrion Blood Albumin Product
Table 87. Kedrion Recent Developments/Updates
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Merck Blood Albumin Product
Table 92. Merck Recent Developments/Updates
Table 93. LFB Group Corporation Information
Table 94. LFB Group Description and Business Overview
Table 95. LFB Group Blood Albumin Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. LFB Group Blood Albumin Product
Table 97. LFB Group Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Blood Albumin Distributors List
Table 101. Blood Albumin Customers List
Table 102. Blood Albumin Market Trends
Table 103. Blood Albumin Growth Drivers
Table 104. Blood Albumin Market Restraints
Table 105. Global Blood Albumin Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Blood Albumin Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Blood Albumin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Blood Albumin Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Blood Albumin Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Blood Albumin Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Blood Albumin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Blood Albumin Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Blood Albumin Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Blood Albumin Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Blood Albumin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Blood Albumin Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Blood Albumin
Figure 2. Global Blood Albumin Market Share by Type in 2020 & 2027
Figure 3. Human Serum Albumin Product Picture
Figure 4. Bovine Serum Albumin Product Picture
Figure 5. Global Blood Albumin Market Share by Application in 2020 & 2027
Figure 6. Therapeutics
Figure 7. Vaccine Ingredient
Figure 8. Culture Medium Ingredient
Figure 9. Other
Figure 10. Global Blood Albumin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Blood Albumin Market Size 2016-2027 (US$ Million)
Figure 12. Global Blood Albumin Sales 2016-2027 (K Units)
Figure 13. Global Blood Albumin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Blood Albumin Sales Share by Manufacturers in 2020
Figure 15. Global Blood Albumin Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Blood Albumin Players: Market Share by Revenue in 2020
Figure 17. Blood Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Blood Albumin Sales Market Share by Region (2016-2021)
Figure 19. Global Blood Albumin Sales Market Share by Region in 2020
Figure 20. Global Blood Albumin Revenue Market Share by Region (2016-2021)
Figure 21. Global Blood Albumin Revenue Market Share by Region in 2020
Figure 22. U.S. Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Blood Albumin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Blood Albumin by Type (2016-2021)
Figure 47. Sales Market Share of Blood Albumin by Application (2016-2021)
Figure 48. Sales Market Share of Blood Albumin by Application in 2020
Figure 49. Revenue Share of Blood Albumin by Application (2016-2021)
Figure 50. Revenue Share of Blood Albumin by Application in 2020
Figure 51. Manufacturing Cost Structure of Blood Albumin
Figure 52. Manufacturing Process Analysis of Blood Albumin
Figure 53. Blood Albumin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed